Clinical Trial

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE -

Study acronym: OXIGENE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The OXIGENE study is a research project that aims to better understand how the immune system behaves in people with lung diseases such as asthma, COPD, pneumonia, tuberculosis, and viral lung infections. By analyzing a single blood sample, the study examines how certain immune cells react during inflammation and infection, and whether lasting changes in these cells influence how strongly the body responds to disease. Although participants do not receive direct medical benefit, the results may help improve future diagnosis and treatment of lung diseases by providing deeper insight into immune responses.
Trial Details
NCT Number NCT07386912
Lead Sponsor Research Center Borstel
Conditions Asthma, COPD, Bacterial Pneumonia, Viral Pneumonia, Tuberculosis
Enrollment 100 participants
Start Date 2026-02-01
Primary Completion 2028-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-04